One patent in respect of one inventive concept: Delhi High Court denies interim injunction to Boehringer in respect of Linagliptin, holds its patent to be vulnerable to revocation.
One patent in respect of one inventive concept: Delhi High Court denies interim injunction to Boehringer in respect of Linagliptin, holds its patent to be vulnerable to revocation.